Interim Report 2026

The Company was established in January 2003 and listed on The Stock Exchange of Hong Kong Limited (stock code: 01099. HK) in September 2009, is a core subsidiary of China National Pharmaceutical Group Co., Ltd. and a top-rank distributor and retailer of pharmaceuticals, medical devices and healthcare products, and a leading supply-chain service provider in the PRC. The Group is mainly engaged in p